Media Diversion in Improving Quality of Life in Patients With Recurrent Gynecologic Cancers Receiving Chemotherapy
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | February 2014 |
End Date: | October 2017 |
The Effects of a Media Diversion on Quality of Life in Patients Receiving Chemotherapy for Recurrent Gynecologic Cancers
This randomized clinical trial studies media diversion in improving quality of life in
patients with recurrent gynecologic cancers receiving chemotherapy. Media diversion may
improve mood and quality of life in patients having cancer treatment.
patients with recurrent gynecologic cancers receiving chemotherapy. Media diversion may
improve mood and quality of life in patients having cancer treatment.
PRIMARY OBJECTIVES:
I. To analyze the impact of a media-based intervention on patient mood during the receipt of
chemotherapy for recurrent gynecologic cancers.
OUTLINE: are randomized to 1 of 2 arms.
ARM I: Participants are provided headphones and a tablet and choose among a selection of
humorous movies. Upon the third course of chemotherapy, participants are provided a
selection of non-humorous movies.
ARM II: Participants are provided headphones and a tablet and choose among a selection of
non-humorous movies. Upon the third course of chemotherapy, participants are provided a
selection of humorous movies.
I. To analyze the impact of a media-based intervention on patient mood during the receipt of
chemotherapy for recurrent gynecologic cancers.
OUTLINE: are randomized to 1 of 2 arms.
ARM I: Participants are provided headphones and a tablet and choose among a selection of
humorous movies. Upon the third course of chemotherapy, participants are provided a
selection of non-humorous movies.
ARM II: Participants are provided headphones and a tablet and choose among a selection of
non-humorous movies. Upon the third course of chemotherapy, participants are provided a
selection of humorous movies.
Inclusion Criteria:
- Subjects with pathologically-proven gynecologic malignancies
- Subjects who have previously completed primary treatment for a gynecologic malignancy
- Patients receiving chemotherapy for a recurrent gynecologic cancer at the University
of Wisconsin-Madison Carbone Cancer Center (UWCCC)
- Patients must be English speaking
- Patients must have the ability to use audio media and read and understand written
English
Exclusion Criteria:
- Patients unable to use audio or video media due to auditory or ocular dysfunction
- Patients unable to read written English
- Patients who are prisoners or incarcerated
We found this trial at
1
site
600 Highland Ave
Madison, Wisconsin 53792
Madison, Wisconsin 53792
(608) 263-6400
Principal Investigator: Stephen L. Rose
Phone: 800-622-8922
University of Wisconsin Hospital and Clinics UW Health strives to meet the health needs of...
Click here to add this to my saved trials